GLP-1 drugs may hold few benefits beyond physical health, study finds
Research from UChicago economist finds no measurable shift in mood, employment or marriage among people taking medications such as Ozempic
New tech shows promise for ‘engineering’ cells to prevent type 1 diabetes
Researchers at UChicago have developed a nanoparticle system that can effectively deliver mRNA to insulin-producing cells, protecting them from the body’s autoimmune response
Albert Bendelac, renowned UChicago pathologist and mentor, 1956-2023
Professor helped establish Committee on Immunology as home of important research, premiere training program for young scientists
Human insulin as safe and effective as costlier insulin analogs
<p>Prof. Elbert S. Huang co-authors study comparing human insulin to insulin analog drugs</p>
Yale News
Two diabetes medications don’t slow progression of type 2 diabetes in youth
<p>RISE study, conducted in part at UChicago Medical Center, finds that tested diabetes medications do not slow the condition’s progression</p>
Could insulin pills prevent diabetes? Big study seeks answer
Article cites study co-authored by Prof. Louis Philipson on preventative diabetes treatments
Associated Press
Rare mutation kills off gene responsible for diabetes
Prof. Louis Philipson comments on significance of finding diabetes-reducing gene mutation for drug development
